Inherited Retinal Disease Market Outlook, Trends And Future Opportunities (2024-2031)

Inherited Retinal Disease Market, By Disease Type (Retinitis Pigmentosa, Stargardt Disease, Leber Congenital Amaurosis, Usher Syndrome, Cone-Rod Dystrophy, Others), By Gene Mutation (RPE65 Mutation, ABCA4 Mutation, USH2A Mutation, RPGR Mutation, CNGA3 Mutation, CNGB3 Mutation, Others), By Treatment Type (Gene Therapy, Stem Cell Therapy, Nutritional Supplements, Low-Vision Aids, Others), By Route of Administration (Intravitreal, Subretinal, Intravenous, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Research Institutes), By Distribution Channel (Direct Tenders, Retail Sales, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.

本报告全面审视了视网膜遗传性疾病的全球市场，从供需两端出发，以助决策者作出明智的决策。该市场按疾病类型（如黄斑变性、星形黄斑变性、利伯先天性黑蒙、乌舍综合征、圆锥-杆状 dystrophy 等）、基因突变（如 RPE65 突变、ABCA4 突变、USH2A 突变、RPGR 突变、CNGA3 突变、CNGB3 突变等）、治疗类型（基因治疗、干细胞治疗、营养补充、低视力辅助工具等）、给药途径（玻璃体注射、视网膜下注射、静脉注射等）、终端用户（医院、专科诊所、门诊手术中心、研究机构等）、分销渠道（直接投标、零售销售等）以及地区（北美、欧洲、亚太、拉丁美洲、中东及非洲）进行细分。